Tyvaso Dpi Kit
NDC Package 66302-620-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Tyvaso Dpi (treprostinil) kits is a medication used to treat a type of high blood pressure in the lungs (pulmonary arterial hypertension). This formulation utilizes a kit delivery system. Marketed by United Therapeutics Corporation, this product is identified by NDC 66302-620 and is authorized under FDA application NDA214324.

Identification & Billing

NDC Package Code
66302-620-03
Package Description
1 KIT in 1 PACKAGE * 4 INHALANT in 1 BLISTER PACK * 4 INHALANT in 1 BLISTER PACK
Product Code
66302-620
11-Digit Billing Format
66302062003
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Tyvaso Dpi
Non-Proprietary Name
Treprostinil
Dosage Form
Kit - A packaged collection of related material.
Usage Information
This medication is used to treat a type of high blood pressure in the lungs (pulmonary arterial hypertension). Treprostinil helps to increase your ability to exercise and improves symptoms such as shortness of breath and tiredness. It works by relaxing and widening the blood vessels (arteries) in the lungs and other parts of the body so that blood can flow more easily. This medication belongs to a class of drugs known as vasodilators.

Regulatory & Marketing

Labeler Name
United Therapeutics Corporation
Product Type
Human Prescription Drug
FDA Application #
NDA214324
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
05-23-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66302-620-03 identifies a specific commercial package of 1 kit in 1 package * 4 inhalant in 1 blister pack * 4 inhalant in 1 blister pack of Tyvaso Dpi, a human prescription drug labeled by United Therapeutics Corporation. This kit is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by United Therapeutics Corporation on May 23, 2022. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat a type of high blood pressure in the lungs (pulmonary arterial hypertension). Treprostinil helps to increase your ability to exercise and improves symptoms such as shortness of breath and tiredness. It works by relaxing and widening the blood vessels (arteries) in the lungs and other parts of the body so that blood can flow more easily. This medication belongs to a class of drugs known as vasodilators.

How is this United Therapeutics Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66302062003. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66302-620-03
11-Digit CMS (5-4-2)
66302-0620-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.